• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Imaging and characterizing influenza A virus mRNA transport

Anne

Senior Moderator
http://nar.oxfordjournals.org/cgi/content/full/36/15/4913


free full text




Imaging and characterizing influenza A virus mRNA transport in living cells

<nobr>Wei Wang<sup>1</sup><sup>,2</sup></nobr>, <nobr>Zong-Qiang Cui<sup>1</sup></nobr>, <nobr>Han Han<sup>1</sup><sup>,2</sup></nobr>, <nobr>Zhi-Ping Zhang<sup>1</sup></nobr>, <nobr>Hong-Ping Wei<sup>1</sup></nobr>, <nobr>Ya-Feng Zhou<sup>1</sup></nobr>, <nobr>Ze Chen<sup>1</sup></nobr> and <nobr>Xian-En Zhang<sup>1</sup><sup>,*</sup></nobr> <sup>1</sup>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071 and <sup>2</sup>Graduate School, Chinese Academy of Sciences, Beijing 100039, China
[SIZE=-1]*To whom correspondence should be addressed. Tel: +86 10 5888 1508; Fax: +86 10 5888 1559; Email: x.zhang@wh.iov.cn<script type="text/javascript"><!-- var u = "x.zhang", d = "wh.iov.cn"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>[/SIZE]
[SIZE=-1]Received April 4, 2008.[/SIZE] [SIZE=-1]Revised June 23, 2008.[/SIZE] [SIZE=-1]Accepted July 8, 2008.[/SIZE]

<!-- null -->
<table width="100%" bgcolor="#e1e1e1" cellpadding="0" cellspacing="0"> <tbody><tr><td valign="middle" width="5%" align="left" bgcolor="#ffffff">
rarrow.gif
</td> <th valign="middle" width="95%" align="left">[SIZE=+2] ABSTRACT [/SIZE]</th></tr></tbody></table> <table align="right" border="1" cellpadding="5"><tbody><tr><th align="left">[SIZE=-1]
[/SIZE]</th></tr></tbody></table>
The mechanisms of influenza A virus mRNA intracellular transport<sup> </sup>are still not clearly understood. Here, we visualized the distribution<sup> </sup>and transport of influenza A virus mRNA in living cells using<sup> </sup>molecular beacon (MB) technology. Confocal-FRAP measurements<sup> </sup>determined that the transport of influenza A virus intronless<sup> </sup>mRNA, in both nucleus and cytoplasm, was energy dependent, being<sup> </sup>similar to that of Poly(A)<sup>+</sup> RNA. Drug inhibition studies in<sup> </sup>living cells revealed that the export of influenza A virus mRNA<sup> </sup>is independent of the CRM1 pathway, while the function of RNA<sup> </sup>polymerase II (RNAP-II) may be needed. In addition, viral NS1<sup> </sup>protein and cellular TAP protein were found associated with<sup> </sup>influenza A virus mRNA in the cell nucleus. These findings characterize<sup> </sup>influenza A virus mRNA transport in living cells and suggest<sup> </sup>that influenza A virus mRNA may be exported from the nucleus<sup> </sup>by the cellular TAP/p15 pathway with NS1 protein and RNAP-II<sup> </sup>participation.<sup> </sup>
<!-- null -->
<table width="100%" bgcolor="#e1e1e1" cellpadding="0" cellspacing="0"> <tbody><tr><td valign="middle" width="5%" align="left" bgcolor="#ffffff">
rarrow.gif
</td> <th valign="middle" width="95%" align="left">[SIZE=+2] INTRODUCTION [/SIZE]</th></tr></tbody></table> <table align="right" border="1" cellpadding="5"><tbody><tr><th align="left">[SIZE=-1]
[/SIZE]</th></tr></tbody></table>
Influenza virus is one of the few RNA viruses to synthesize<sup> </sup>its mRNA in the nucleus of infected cells (1). The virus mRNAs<sup> </sup>are potential substrates for the cellular splicing machinery<sup> </sup>and need to be exported from the nucleus to enable the viral<sup> </sup>proteins to be synthesized (2). Uncovering the mechanisms of<sup> </sup>influenza virus mRNA export is of great importance to truly<sup> </sup>understand the replication and pathogenicity of the virus. The<sup> </sup>nuclear export of cellular mRNA is mediated by several proteins<sup> </sup>that bind to mRNA and to pre-mRNA precursors (3). However, unlike<sup> </sup>cellular intron-containing mRNAs, most influenza virus mRNAs<sup> </sup>are intronless. Hence, the export mechanisms of viral intronless<sup> </sup>mRNAs might be different from those of cellulr mRNAs. Moreover,<sup> </sup>because there are three different types of influenza virus mRNA,<sup> </sup>more than one mechanism of nuclear export might operate in virus-infected<sup> </sup>cells (1). The first type of influenza virus mRNA includes intronless<sup> </sup>mRNAs, such as PA, PB1, PB2, HA, NA and NP mRNA. The second<sup> </sup>type of viral mRNA consists of the M1 and NS1 mRNAs, which contain<sup> </sup>introns but do not undergo splicing. The M2 and NS2 mRNAs, which<sup> </sup>are produced by splicing, comprise the third type of viral mRNA.<sup> </sup>The mechanisms of the nuclear export of these three types of<sup> </sup>influenza A virus mRNA remain unknown.<sup> </sup>
Two pathways have been described that appear to be responsible<sup> </sup>for the export of viral mRNA (4). The first RNA export pathway<sup> </sup>was the CRM1 pathway, which is utilized by human immunodeficiency<sup> </sup>virus (HIV) through the mediation of the Rev protein (5). Herpes<sup> </sup>simplex virus (HSV) also utilizes CRM1 to export its mRNA (6).<sup> </sup>However, other studies showed that CRM1 may be not a major contributor<sup> </sup>to mRNA export in metazoans or yeast (7,8). The human protein<sup> </sup>TAP, and its yeast ortholog Mex67p, might be the best candidates<sup> </sup>for mRNA export receptors because they shuttle between the nucleus<sup> </sup>and cytoplasm, cross-link to poly(A)<sup>+</sup> RNA, localize at the nuclear<sup> </sup>pores and interact directly with nucleoporins (9?12).<sup> </sup>The TAP pathway was reported to be used by HSV ICP27 to export<sup> </sup>its intronless mRNAs (4). Moreover, TAP protein could also promote<sup> </sup>the export of constitutive transport element (CTE) containing<sup> </sup>transcripts of some virus such as type D retrovirus (9,10,13).<sup> </sup>Influenza A virus mRNA may, therefore, be exported from the<sup> </sup>nucleus by the CRM1 dependent pathway or by the TAP/p15 pathway.<sup> </sup>Previous studies have shown that influenza virus NS1 protein<sup> </sup>could selectively inhibit cellular mRNA export by binding with<sup> </sup>CPSF and PABII (1), or by forming an inhibitory complex with<sup> </sup>cellular mRNA export factors TAP and p15 (14). Moreover, NS1<sup> </sup>can also inhibit the splicing and export of its own mRNA, in<sup> </sup>an RNA binding-dependent manner (2). Nevertheless, the mechanisms<sup> </sup>by which influenza virus mRNAs are exported from the nucleus<sup> </sup>and the roles of viral NS1 protein in influenza A virus intronless<sup> </sup>mRNA export are still unclear.<sup> </sup>
The ability to accurately and repeatedly track mRNA in living<sup> </sup>mammalian cells would help us to fully understand the mRNA transport<sup> </sup>mechanism. There are a variety of tools currently used to visualize<sup> </sup>intracellular mRNAs, including molecular beacons (MBs) and fluorescently<sup> </sup>labeled oligonucleotide probes. MBs are a powerful and simple<sup> </sup>tool for cellular mRNA and viral RNA visualization in living<sup> </sup>cells (15?21). Live-cell imaging of mRNA could shed light<sup> </sup>on many fundamental processes, such as the kinetics of mRNA<sup> </sup>production, mRNA localization and transportation inside a cell<sup> </sup>and cellular responses to virus infection and to virus?host<sup> </sup>interaction. We, therefore, used MBs as a detection probe to<sup> </sup>track influenza A virus mRNA in living host cells, in order<sup> </sup>to explore the mechanisms of viral mRNA export.<sup> </sup>
In this study, we successfully visualized influenza A virus<sup> </sup>mRNA in living mammalian cells, and studied the dynamic behaviors<sup> </sup>of influenza virus mRNA by Confocal-FRAP experiments. By imaging<sup> </sup>experiments of living cells and protein immunofluorescence analysis<sup> </sup>in fixed cells, it was found that influenza A virus mRNAs could<sup> </sup>colocalize with viral NS1 and cellular TAP protein in cell nucleus.<sup> </sup>Moreover, coimmunoprecipitation experiments of influenza A virus<sup> </sup>mRNAs with NS1 and TAP protein revealed that NS1 and TAP protein<sup> </sup>could be physically associated with both intron-containing and<sup> </sup>intronless mRNAs of influenza A virus. By performing Actinomycin<sup> </sup>D (ActD) inhibition experiments in living cells we observed<sup> </sup>that RNA polymerase II (RNAP-II) and other factors might be<sup> </sup>involved in influenza virus mRNA export. Furthermore, Leptomycin<sup> </sup>B (LMB), a specific inhibitor of CRM1, could not inhibit influenza<sup> </sup>A virus mRNA export in living cells. Therefore, influenza A<sup> </sup>virus mRNA export may be independent of CRM1. Together, these<sup> </sup>results indicate that the cellular transport of influenza A<sup> </sup>virus mRNA may be energy dependent and utilize the cellular<sup> </sup>TAP/p15 transport pathway with the participation of viral NS1<sup> </sup>protein and cellular RNAP-II.
 
Back
Top